Site navigation

Navigation

Laparoscopic laser myomectomy

 
Guidance issued
 
IPG Number: IPG23

Summary

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on laparoscopic laser myomectomy.

 

Further recommendations have been made as part of the clinical guideline on heavy menstrual bleeding published in January 2007. Clinical and cost-effectiveness evidence was reviewed in the development of this guideline which has led to this more specific recommendation. The IP guidance on Laparoscopic laser myomectomy disease remains current, and should be read in conjunction with the clinical guideline.

Description

This procedure is used to treat uterine fibroids (leiomyomas).

Fibroids are benign tumours of the uterine muscle. They are very common. They may cause pain, heavy menstrual bleeding (menorrhagia) and reduced fertility.

Hysterectomy is the standard treatment for women with fibroids whose symptoms have not resolved with medical treatment. Laparoscopic myomectomy is the destruction of fibroids via a laparoscope passed through a small incision in the abdomen and then through the wall of the uterus. The fibroids may be destroyed with a laser or electrocautery.

OPCS code:

Details

Arrangement:
Special
Topic area:
Gynaecology, pregnancy and birth
Surgical procedures
Specialty:
General surgery
Obstetrics and gynaecology
Specialist advice has been sought from:
Royal College of Obstetricians and Gynaecologists
Date notified to NICE:
01 April 2002
Guidance issue date:
26 November 2003

Contact details:

Project manager (for general enquiries or comments)
(for general enquiries or comments)
Ben Doak
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA

Links: